Shenyang Xingqi (China) Today
| 300573 Stock | 71.20 1.37 1.89% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Shenyang Xingqi is trading at 71.20 as of the 2nd of March 2025, a 1.89 percent decrease since the beginning of the trading day. The stock's open price was 72.57. Shenyang Xingqi has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 2nd of December 2024 and ending today, the 2nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shenyang Xingqi is entity of China. It is traded as Stock on SHE exchange. The company has 175.25 M outstanding shares. More on Shenyang Xingqi Pharmaceutical
Moving together with Shenyang Stock
Moving against Shenyang Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shenyang Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shenyang Xingqi's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shenyang Xingqi or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Mang | Kun Zhang | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Shenyang Xingqi's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shenyang Xingqi's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShenyang Xingqi can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shenyang Xingqi's financial leverage. It provides some insight into what part of Shenyang Xingqi's total assets is financed by creditors.
| |||||
Shenyang Xingqi Pharmaceutical (300573) is traded on Shenzhen Stock Exchange in China and employs 1,995 people. Shenyang Xingqi is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shenyang Xingqi's market, we take the total number of its shares issued and multiply it by Shenyang Xingqi's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shenyang Xingqi Phar operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 175.25 M outstanding shares.
Shenyang Xingqi generates positive cash flow from operations, but has no cash available
Check Shenyang Xingqi Probability Of Bankruptcy
Ownership AllocationShenyang Xingqi Phar shows a total of 175.25 Million outstanding shares. Shenyang Xingqi Phar maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shenyang Ownership Details
Shenyang Xingqi Phar Risk Profiles
Although Shenyang Xingqi's alpha and beta are two of the key measurements used to evaluate Shenyang Xingqi's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.75 | |||
| Standard Deviation | 2.33 | |||
| Variance | 5.43 | |||
| Risk Adjusted Performance | (0.07) |
Shenyang Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shenyang Xingqi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Shenyang Xingqi Corporate Directors
| Qiang Yang | Deputy Director | Profile | |
| Gao | GM Director | Profile | |
| Yanan Cheng | CFO Director | Profile | |
| Chunhua Li | Director Director | Profile |
Other Information on Investing in Shenyang Stock
Shenyang Xingqi financial ratios help investors to determine whether Shenyang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenyang with respect to the benefits of owning Shenyang Xingqi security.